Table 1.
Panel of Breast Cancer Cell Lines
| Mutation Status | |||
|---|---|---|---|
| Cell Line | Subclass | PTENa | PI3Kb |
| MCF7 | ERc | WTd | E545K |
| T47D | ER | WT | H1047R |
| MDA-MB-231 | TNe | WT | WT |
| MDA-MB-157 | TN | WT | WT |
| HCC1569 | HER2f | WT | WT |
| SKBR3 | HER2 | WT | WT |
| HCC1954 | HER2 | ?g | H1047R |
| KPL4 | HER2 | ? | H1047R |
Phosphatase and tensin homolog.
Phosphoinsitide-3-kinase.
Estrogen receptor.
Wild type.
Triple negative.
Human epidermal growth factor receptor 2.
Lack of consensus regarding the mutational status of those cell lines.
ER, estrogen receptor; HER2, human epidermal growth factor; PI3K, phosphoinositide 3-kinase; PTEN, phosphatase and tensin homolog; TN, triple negative; WT, wild type.